ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 43 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,551,000 | -9.8% | 2,415,000 | -9.4% | 0.01% | 0.0% |
| Q2 2017 | $2,827,000 | +10.1% | 2,665,000 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $2,567,000 | +41.3% | 2,665,000 | +36.5% | 0.01% | +33.3% |
| Q3 2016 | $1,817,000 | +21.6% | 1,953,000 | -7.6% | 0.01% | 0.0% |
| Q2 2016 | $1,494,000 | – | 2,113,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 16,935,000 | $17,946,697,000 | 3.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,700,000 | $48,504,000 | 2.18% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $21,312,000 | 1.66% |
| LINDEN ADVISORS LP | 34,494,000 | $36,562,000 | 1.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 96,239,000 | $101,731,000 | 1.13% |
| MACKAY SHIELDS LLC | 24,155,000 | $25,567,000 | 0.95% |
| Verition Fund Management LLC | 10,200,000 | $10,799,000 | 0.87% |
| Jabre Capital Partners S.A. | 4,000,000 | $4,243,000 | 0.82% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 38,030,000 | $40,330,000 | 0.76% |
| AQR Arbitrage LLC | 44,600,000 | $47,220,000 | 0.51% |